BTG is a specialty pharmaceuticals company that is developing and commercialising products targeting critical care, cancer, neurological and other disorders. The company is also seeking to acquire ...

Investors in B2Gold Corp. BTG need to pay close attention to the stock based on moves in the options market lately. That is because the March 21, 2025 $3.5 Put had some of the highest implied ...

B2Gold Corp (BTG) met its guidance for 2024, achieving the upper end of all sustaining costs and the lower end of production. The company anticipates a more positive 2025 with increased production ...

January 7, 2025 Swiss bank Julius Baer sells Brazil wealth business to BTG Pactual Julius Baer said on Tuesday it had agreed to sell its Brazilian domestic wealth management business to Banco BTG ...